KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Free Cash Flow (2019 - 2025)

Historic Free Cash Flow for Hims & Hers Health (HIMS) over the last 7 years, with Q3 2025 value amounting to $83.5 million.

  • Hims & Hers Health's Free Cash Flow rose 186.88% to $83.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.9 million, marking a year-over-year decrease of 1677.77%. This contributed to the annual value of $209.4 million for FY2024, which is 27226.06% up from last year.
  • Hims & Hers Health's Free Cash Flow amounted to $83.5 million in Q3 2025, which was up 186.88% from -$65.2 million recorded in Q2 2025.
  • In the past 5 years, Hims & Hers Health's Free Cash Flow ranged from a high of $83.5 million in Q3 2025 and a low of -$65.2 million during Q2 2025
  • Moreover, its 5-year median value for Free Cash Flow was $7.6 million (2023), whereas its average is $14.1 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first tumbled by 144349.59% in 2022, then surged by 36345.87% in 2024.
  • Hims & Hers Health's Free Cash Flow (Quarter) stood at -$4.0 million in 2021, then tumbled by 96.43% to -$7.9 million in 2022, then soared by 268.33% to $13.4 million in 2023, then surged by 363.46% to $61.9 million in 2024, then surged by 34.87% to $83.5 million in 2025.
  • Its Free Cash Flow stands at $83.5 million for Q3 2025, versus -$65.2 million for Q2 2025 and $53.8 million for Q1 2025.